Trump Budget's Prescription Drug Proposals Would Lower Patients' Costs and Federal Spending; Some Could Lower Drug Prices

The Trump administration laid out a package of proposals to lower prescription drug costs in the president’s budget for fiscal year 2019. In a post on To the Point, former U.S. congressman Henry Waxman, Bill Corr, and Kristi Martin explain that as a package, the proposals could help decrease patient costs for drugs and reduce federal spending. However, not all the president’s proposals are designed to lower drug prices or have the same impact on patients and federal spending. The authors offer a close look at the policy changes and any associated savings, which affect Medicaid, Medicare, and other programs.